CA242 Antibody (1A6), mAb, Mouse

CA242 (1A6), mAb, Mouse

CA242, known as carbohydrate antigen 242, is a sialyated carbohydrate antigen. It is a cancer-associated glycoprotein expressed in the sera of pancreatic cancer patients. CA242 is a useful biomarker for the diagnosis, prognosis, and surveillance of gastrointestinal malignancies.
V06001
¥59,161.00

Ask us a question
Overview
Specificity Human CA242
Recommended Pairs CLIA (Capture-Detection):
1A6 - 1E1HC
Clone ID 1A6
Isotype Mouse IgG1 for mAb 1A6
Subclass IgG1
Host Species Mouse
Antigen Species Human

Properties
Conjugation Unconjugated
Production Cultured in vitro under conditions free from animal-derived components
Purification Protein A/G affinity column
Concentration ≥ 2mg/ml
Formulation 50 mM Na-citrate, 150 mM NaCl, pH 7.0, containing 0.03% ProClin 300.
Storage For long term storage, aliquot and store at -25°C~-15°C or below. Avoid repeated freezing and thawing cycles.
Note GenScript can customize this product per customer's request including product size, buffer components, etc.

Applications
Platform Capture Detection
CLIA 1A6 1E1HC

Background
Target Background CA242, known as carbohydrate antigen 242, is a sialyated carbohydrate antigen. It is a cancer-associated glycoprotein expressed in the sera of pancreatic cancer patients. CA242 is a useful biomarker for the diagnosis, prognosis, and surveillance of gastrointestinal malignancies.

Limited Use License and Use Restrictions
Limited Use License and Use Restrictions This Product is provided under a limited, non-exclusive, non-transferable, and non-sublicensable end-user license strictly limited to the permitted uses set forth in GenScript’s official documentation, quotations, or written agreements. Any use beyond such scope requires GenScript’s prior written authorization or license.
Except as expressly authorized in writing by GenScript, Customer shall not, and shall not permit, procure, enable, or assist any third party to: (a) commercialize or otherwise exploit the Product, including by reselling, distributing, transferring, sublicensing, or otherwise making the Product (including any product incorporating the Product) available to any third party; (b) copy, reproduce, clone, reverse clone, sequence, analyze, characterize, deconstruct, reconstruct, reverse engineer, or otherwise attempt to discover the composition, sequence, structure, binding characteristics, epitope recognition characteristics, or other proprietary features of the Product; (c) modify, derivatize, humanize, optimize, mutate, design around, or generate any variants, derivatives, fragments, substitutes, or functional equivalents of the Product; or (d) use the Product, any information derived therefrom, or any computational, AI-enabled, or sequence-based design method to develop, manufacture, offer for sale, sell, or commercialize any product or service competitive with the Product or GenScript’s products or services.
All intellectual property rights and all rights not expressly granted herein are reserved by GenScript. No rights are granted by implication, estoppel, or otherwise.

For laboratory research use only. Direct human use, including taking orally and injection and clinical use are forbidden.